A new health technology stock has come on the scene. Omada Health made its debut on the NYSE today, and received a warm welcome. OMDA shares are soaring by nearly 40% today to over $26 per share, ...
Omada Health (OMDA) will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada’s behavior change program on members currently or previously on GLP-1 medications for weight ...
“I’m proud of our second quarter results, with 49% year-over-year revenue growth, strong margin improvements, and continued progress toward profitability,” said Sean Duffy, Co-founder and CEO of Omada ...
SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Omada Health (OMDA) (Nasdaq: OMDA), the virtual between-visit healthcare provider, released results from a real-world analysis that showed 63% of ...
Hosted on MSN
Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows
Virtual care company Omada Health said it will start prescribing GLP-1s and other obesity drugs and help patients manage those medications. The announcement expands the offerings under the company's ...
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2025 results on ...
Great. Well, good afternoon, everyone. I'm Craig Hettenbach. I cover the health tech and provider space for Morgan Stanley. Thanks for being here, day 2 at the conference. And we'll close out, I think ...
Revenue of $68 million, up 49%; 53%Member Growth Significant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDA Announces New GLP-1 Prescribing Offering SAN FRANCISCO, Nov. 06, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback